Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
New real-world data analysis finds no evidence of increased risk of hospitalisation for heart failure with saxagliptin compared with sitagliptin
-
AstraZeneca presents new positive phase III data on triple therapy approach with dapagliflozin, saxagliptin and metformin for the treatment of type 2 diabetes
-
AstraZeneca to present data demonstrating progress of its comprehensive diabetes portfolio at the American Diabetes Association 75th Scientific Sessions
-
AstraZeneca updates on immuno-oncology combinations development programme at the 2015 ASCO Annual Meeting
-
AstraZeneca and MedImmune present positive immuno-oncology combination data at the 2015 ASCO Annual Meeting
-
AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours
-
AstraZeneca provides update on brodalumab development programme
-
AstraZeneca to invest in new biologics manufacturing facility in Södertälje, Sweden, to support accelerating biologics portfolio
-
AstraZeneca and Montreal Heart Institute to screen 80,000 samples for cardiovascular and diabetes genetic traits
-
AstraZeneca and Abbott to develop companion diagnostic tests for tralokinumab in severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
